George Magrath, Chief Executive Officer at Ocuphire Pharma, Inc. (OCUP), bought 25,000 shares at $1.96 ($49K) on 2024-03-18, disclosed to the SEC on 2024-03-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| IRD | SELL | 2026-03-18 | $255K | — | Filing → |
| IRD | BUY | 2024-12-30 | $98K | — | Filing → |
| IRD | BUY | 2024-11-19 | $192K | — | Filing → |